- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Applied Therapeutics Inc (APLT)
Applied Therapeutics Inc stock price live, this page displays NASDAQ APLT stock exchange data. View the APLT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Applied Therapeutics Inc real time stock price chart below.
What Is the Applied Therapeutics Inc Stock Price Today?
The Applied Therapeutics Inc stock price today is 0.521.
What Is the Stock Symbol for Applied Therapeutics Inc?
The stock symbol for Applied Therapeutics Inc is ""APLT.""
What Stock Exchange Does Applied Therapeutics Inc Trade On?
Applied Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Applied Therapeutics Inc a Good Stock to Buy?
Determining whether Applied Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the APLT quote. (ISIN: US03828A1016)
What Is the Applied Therapeutics Inc Stock Price Today?
The Applied Therapeutics Inc stock price today is 0.521.
What Is the Stock Symbol for Applied Therapeutics Inc?
The stock symbol for Applied Therapeutics Inc is ""APLT.""
What Stock Exchange Does Applied Therapeutics Inc Trade On?
Applied Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Applied Therapeutics Inc a Good Stock to Buy?
Determining whether Applied Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the APLT quote. (ISIN: US03828A1016)
0.521
+0.006(+1.21%)
Real-time Data·
Fair Value
An estimate of a Applied Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.500
0.523
52 wk Range
0.295
10.624
APLT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
APLT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Applied Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.5000.523
52 wk Range
0.29510.624
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
APLT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Applied Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
3.167
Upside
+507.81%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Applied Therapeutics Inc Company Profile
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company’s lead product candidate is AT-007 that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It develops AT-001 that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Applied Therapeutics Inc SWOT Analysis
Regulatory Progress | Explore Applied Therapeutics' positive FDA feedback on galactosemia treatment and potential accelerated approval for SORD therapy, signaling promising regulatory momentum |
Market Expansion | Discover how revised SORD prevalence estimates have significantly increased Applied Therapeutics' addressable market, potentially boosting long-term revenue projections |
Pipeline Potential | Delve into Applied Therapeutics' focus on galactosemia and SORD deficiency, positioning the company as a pioneer in addressing these rare genetic disorders |
Financial Outlook | Analyst price targets range from $2 to $13, reflecting the speculative nature of Applied Therapeutics' development stage and the potential impact of regulatory decisions |
Compare APLT to Peers and Sector
Metrics to compare | APLT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAPLTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | −0.6x | −0.6x | |
PEG Ratio | −0.02 | −0.02 | 0.00 | |
Price/Book | 4.2x | 0.9x | 2.6x | |
Price / LTM Sales | 605.8x | 8.6x | 3.3x | |
Upside (Analyst Target) | - | 287.9% | 39.0% | |
Fair Value Upside | Unlock | 27.8% | 4.9% | Unlock |
Analyst Ratings
2 Buy
2 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3.167
(+507.81% Upside)
Earnings
Latest Release
Aug 13, 2025
EPS / Forecast
-0.15 / -0.17
Revenue / Forecast
-- / 312.50K
People Also Watch
FAQ
What Stock Exchange Does Applied Therapeutics Trade On?
Applied Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Applied Therapeutics?
The stock symbol for Applied Therapeutics is "APLT."
What Is the Applied Therapeutics Market Cap?
As of today, Applied Therapeutics market cap is 73.88M.
What Is Applied Therapeutics's Earnings Per Share (TTM)?
The Applied Therapeutics EPS (TTM) is -0.47.
When Is the Next Applied Therapeutics Earnings Date?
Applied Therapeutics will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is APLT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Applied Therapeutics Stock Split?
Applied Therapeutics has split 0 times.
How Many Employees Does Applied Therapeutics Have?
Applied Therapeutics has 32 employees.
What is the current trading status of Applied Therapeutics (APLT)?
As of 26 Aug 2025, Applied Therapeutics (APLT) is trading at a price of 0.52, with a previous close of 0.52. The stock has fluctuated within a day range of 0.50 to 0.52, while its 52-week range spans from 0.30 to 10.62.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.